Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm O'Morain

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Inflammatory Bowel Diseases|February 6, 2007
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel DiseaseShmuel Odes, Michael Friger, Hillel Vardi, et al.
Gastroenterology|January 4, 2024
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Yi-Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classificationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Journal of Clinical Gastroenterology|January 6, 2021
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Bojan Tepes, et al.
Scandinavian Journal of Gastroenterology|June 17, 2020
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.
Nature Genetics|December 15, 2010
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel diseaseYukihide Momozawa, Myriam Mni, Kayo Nakamura, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Inflammatory Bowel Diseases|February 6, 2007
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel DiseaseShmuel Odes, Michael Friger, Hillel Vardi, et al.
Gastroenterology|January 4, 2024
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Yi-Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classificationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Journal of Clinical Gastroenterology|January 6, 2021
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Bojan Tepes, et al.
Scandinavian Journal of Gastroenterology|June 17, 2020
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.
Nature Genetics|December 15, 2010
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel diseaseYukihide Momozawa, Myriam Mni, Kayo Nakamura, et al.
Pageof 15